Tocilizumab as first treatment option in optic neuropathy secondary to Graves’ orbitopathy

I. Pascual-Camps, R. Molina-Pallete, M. A. Bort-Martí, J. Todolí, E. España-Gregori
  • Orbit, February 2018, Taylor & Francis
  • DOI: 10.1080/01676830.2018.1435694

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/01676830.2018.1435694

The following have contributed to this page: Enrique España-Gregori

In partnership with: